Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.47679451 |
2 | immunoglobulin mediated immune response (GO:0016064) | 5.10830153 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.09990854 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03056008 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.82904504 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.80277729 |
7 | negative regulation of cell killing (GO:0031342) | 4.63550721 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.63550721 |
9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49564519 |
10 | B cell mediated immunity (GO:0019724) | 4.23346803 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15011053 |
12 | negative regulation of interleukin-12 production (GO:0032695) | 4.11819243 |
13 | response to peptidoglycan (GO:0032494) | 4.06568029 |
14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.95382916 |
15 | neutrophil activation (GO:0042119) | 3.93626481 |
16 | granulocyte activation (GO:0036230) | 3.85413182 |
17 | positive regulation of mast cell activation (GO:0033005) | 3.80833203 |
18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.76310449 |
19 | modulation by symbiont of host defense response (GO:0052031) | 3.76310449 |
20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.76310449 |
21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.76310449 |
22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.76310449 |
23 | modulation by symbiont of host immune response (GO:0052553) | 3.76310449 |
24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.71782803 |
25 | detection of other organism (GO:0098543) | 3.63144193 |
26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.62085575 |
27 | macrophage activation involved in immune response (GO:0002281) | 3.57767305 |
28 | leukocyte aggregation (GO:0070486) | 3.57666826 |
29 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.56257398 |
30 | positive regulation of mast cell degranulation (GO:0043306) | 3.56257398 |
31 | detection of bacterium (GO:0016045) | 3.48782092 |
32 | myeloid cell activation involved in immune response (GO:0002275) | 3.46958322 |
33 | regulation of hypersensitivity (GO:0002883) | 3.45726777 |
34 | microglial cell activation (GO:0001774) | 3.45411044 |
35 | regulation of T cell tolerance induction (GO:0002664) | 3.44701564 |
36 | regulation of mast cell degranulation (GO:0043304) | 3.44506087 |
37 | detection of molecule of bacterial origin (GO:0032490) | 3.43315158 |
38 | T cell migration (GO:0072678) | 3.42929666 |
39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.41043915 |
40 | cellular response to type I interferon (GO:0071357) | 3.40587332 |
41 | type I interferon signaling pathway (GO:0060337) | 3.40587332 |
42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39119849 |
43 | mast cell activation (GO:0045576) | 3.39103643 |
44 | response to type I interferon (GO:0034340) | 3.36595354 |
45 | detection of external biotic stimulus (GO:0098581) | 3.32322526 |
46 | regulation of tolerance induction (GO:0002643) | 3.30718003 |
47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29086190 |
48 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.28784163 |
49 | regulation of mast cell activation (GO:0033003) | 3.28337517 |
50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23229869 |
51 | positive regulation of B cell differentiation (GO:0045579) | 3.20975209 |
52 | cellular extravasation (GO:0045123) | 3.20077843 |
53 | regulation of antigen processing and presentation (GO:0002577) | 3.19464811 |
54 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.19149300 |
55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19034734 |
56 | cytidine metabolic process (GO:0046087) | 3.16939734 |
57 | cytidine catabolic process (GO:0006216) | 3.16939734 |
58 | cytidine deamination (GO:0009972) | 3.16939734 |
59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16270497 |
60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16190395 |
61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16126577 |
62 | positive thymic T cell selection (GO:0045059) | 3.15846184 |
63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15668500 |
64 | respiratory burst (GO:0045730) | 3.15478195 |
65 | lymphocyte chemotaxis (GO:0048247) | 3.14110961 |
66 | defense response to protozoan (GO:0042832) | 3.10389636 |
67 | positive regulation of B cell mediated immunity (GO:0002714) | 3.02731561 |
68 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.02731561 |
69 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02465342 |
70 | positive regulation of type 2 immune response (GO:0002830) | 3.01819296 |
71 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.00741434 |
72 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.00177692 |
73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.98901069 |
74 | cellular response to interferon-gamma (GO:0071346) | 2.98269607 |
75 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.98264152 |
76 | detection of biotic stimulus (GO:0009595) | 2.97978128 |
77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97620542 |
78 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96861833 |
79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96097266 |
80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95557908 |
81 | response to interferon-beta (GO:0035456) | 2.94967220 |
82 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94825616 |
83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94825616 |
84 | macrophage activation (GO:0042116) | 2.93423511 |
85 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93217081 |
86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.90539927 |
87 | negative T cell selection (GO:0043383) | 2.90389339 |
88 | T cell costimulation (GO:0031295) | 2.90117009 |
89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88776279 |
90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88030472 |
91 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87902466 |
92 | lymphocyte costimulation (GO:0031294) | 2.86367368 |
93 | regulation of B cell differentiation (GO:0045577) | 2.86354365 |
94 | positive regulation of interleukin-17 production (GO:0032740) | 2.86026026 |
95 | response to interleukin-15 (GO:0070672) | 2.84683528 |
96 | response to interferon-gamma (GO:0034341) | 2.84485142 |
97 | response to protozoan (GO:0001562) | 2.83441304 |
98 | positive regulation of tolerance induction (GO:0002645) | 2.82841656 |
99 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82603193 |
100 | negative thymic T cell selection (GO:0045060) | 2.82182015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.59448009 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.92964191 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.28400085 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.41289277 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14006029 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90922683 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.77928182 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34781198 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.27630959 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05654758 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.77604898 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75006823 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69103422 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68168511 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.66029315 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65027768 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.55616913 |
18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.55023059 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49510798 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37650103 |
21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.34346423 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23399578 |
23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14527157 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12829537 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11800595 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98060795 |
27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94301995 |
28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.91320250 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91283858 |
30 | MYB_26560356_Chip-Seq_TH1_Human | 1.89364006 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87133813 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 1.85813334 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85718423 |
34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82915019 |
35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80668442 |
36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.79877486 |
37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78043622 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77542700 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77159310 |
40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.76288432 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71582724 |
42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67121893 |
43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62369034 |
44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59852073 |
45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52472387 |
46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48946547 |
47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44246292 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.30653331 |
49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29693067 |
50 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29509534 |
51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29255428 |
52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27573152 |
53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26870055 |
54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25412052 |
55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25140461 |
56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23294761 |
57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22348686 |
58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16658338 |
59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15982946 |
60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14758291 |
61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11819763 |
62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11654455 |
63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11423042 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09793375 |
65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06386750 |
66 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04822804 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04520826 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99625509 |
69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99248865 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99002524 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98418726 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92280351 |
73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91185318 |
74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89964862 |
75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89926261 |
76 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89387131 |
77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89380462 |
78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87466270 |
79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85979695 |
80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85958918 |
81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83916560 |
82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.79971993 |
83 | P300_27268052_Chip-Seq_Bcells_Human | 0.79282877 |
84 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77138247 |
85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75902526 |
86 | MYC_22102868_ChIP-Seq_BL_Human | 0.74909900 |
87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74519791 |
88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74480768 |
89 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74438317 |
90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74398202 |
91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73577968 |
92 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72709699 |
93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70429519 |
94 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66638936 |
95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.66033384 |
96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.64674159 |
97 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64113074 |
98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.64057119 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61872678 |
100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.61809998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.86059254 |
2 | MP0003724_increased_susceptibility_to | 4.20761616 |
3 | MP0005671_abnormal_response_to | 4.12201101 |
4 | MP0009785_altered_susceptibility_to | 3.51843332 |
5 | MP0003436_decreased_susceptibility_to | 3.40940152 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.26032255 |
7 | MP0003303_peritoneal_inflammation | 3.24307590 |
8 | MP0005000_abnormal_immune_tolerance | 3.22537042 |
9 | MP0006082_CNS_inflammation | 3.18623852 |
10 | MP0001800_abnormal_humoral_immune | 3.00303442 |
11 | MP0005025_abnormal_response_to | 2.98038126 |
12 | MP0002419_abnormal_innate_immunity | 2.91248535 |
13 | MP0001790_abnormal_immune_system | 2.85721298 |
14 | MP0005387_immune_system_phenotype | 2.85721298 |
15 | MP0002723_abnormal_immune_serum | 2.73476884 |
16 | MP0002452_abnormal_antigen_presenting | 2.68283331 |
17 | MP0000685_abnormal_immune_system | 2.66713669 |
18 | MP0005464_abnormal_platelet_physiology | 2.55603645 |
19 | MP0002420_abnormal_adaptive_immunity | 2.50995752 |
20 | MP0001819_abnormal_immune_cell | 2.48586773 |
21 | MP0010155_abnormal_intestine_physiology | 2.21522731 |
22 | MP0009764_decreased_sensitivity_to | 2.15228111 |
23 | MP0001845_abnormal_inflammatory_respons | 1.98551554 |
24 | MP0003763_abnormal_thymus_physiology | 1.98286722 |
25 | MP0009333_abnormal_splenocyte_physiolog | 1.96243819 |
26 | MP0001533_abnormal_skeleton_physiology | 1.91356614 |
27 | MP0003806_abnormal_nucleotide_metabolis | 1.88566859 |
28 | MP0000716_abnormal_immune_system | 1.85545074 |
29 | MP0002405_respiratory_system_inflammati | 1.85123332 |
30 | MP0002398_abnormal_bone_marrow | 1.79352580 |
31 | MP0003075_altered_response_to | 1.76558276 |
32 | MP0004947_skin_inflammation | 1.76087926 |
33 | MP0003300_gastrointestinal_ulcer | 1.74411672 |
34 | MP0005058_abnormal_lysosome_morphology | 1.72201379 |
35 | MP0000858_altered_metastatic_potential | 1.62717630 |
36 | MP0008469_abnormal_protein_level | 1.62089064 |
37 | MP0003866_abnormal_defecation | 1.54919842 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.53052557 |
39 | MP0000343_altered_response_to | 1.51305602 |
40 | MP0000689_abnormal_spleen_morphology | 1.47951935 |
41 | MP0002166_altered_tumor_susceptibility | 1.46999893 |
42 | MP0001853_heart_inflammation | 1.46608693 |
43 | MP0002429_abnormal_blood_cell | 1.45308337 |
44 | MP0005166_decreased_susceptibility_to | 1.43626870 |
45 | MP0002722_abnormal_immune_system | 1.41215306 |
46 | MP0001873_stomach_inflammation | 1.39833488 |
47 | MP0003448_altered_tumor_morphology | 1.38211345 |
48 | MP0008004_abnormal_stomach_pH | 1.33416648 |
49 | MP0005310_abnormal_salivary_gland | 1.33303216 |
50 | MP0003172_abnormal_lysosome_physiology | 1.31869535 |
51 | MP0004510_myositis | 1.30895161 |
52 | MP0002998_abnormal_bone_remodeling | 1.27800065 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.26803448 |
54 | MP0009278_abnormal_bone_marrow | 1.23790463 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.16382706 |
56 | MP0001545_abnormal_hematopoietic_system | 1.16382706 |
57 | MP0002138_abnormal_hepatobiliary_system | 1.14877851 |
58 | MP0009763_increased_sensitivity_to | 1.14621308 |
59 | MP0002006_tumorigenesis | 1.10757691 |
60 | MP0006054_spinal_hemorrhage | 1.08125399 |
61 | MP0001663_abnormal_digestive_system | 1.02890093 |
62 | MP0000703_abnormal_thymus_morphology | 1.02720587 |
63 | MP0003828_pulmonary_edema | 0.98471767 |
64 | MP0002277_abnormal_respiratory_mucosa | 0.96270911 |
65 | MP0003183_abnormal_peptide_metabolism | 0.93991944 |
66 | MP0000604_amyloidosis | 0.93095596 |
67 | MP0002132_abnormal_respiratory_system | 0.92663343 |
68 | MP0004883_abnormal_blood_vessel | 0.89138908 |
69 | MP0008260_abnormal_autophagy | 0.89090621 |
70 | MP0005164_abnormal_response_to | 0.88027955 |
71 | MP0009840_abnormal_foam_cell | 0.84123263 |
72 | MP0002933_joint_inflammation | 0.81572691 |
73 | MP0001851_eye_inflammation | 0.80772488 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 0.79304476 |
75 | MP0005390_skeleton_phenotype | 0.77995053 |
76 | MP0000249_abnormal_blood_vessel | 0.76379424 |
77 | MP0005167_abnormal_blood-brain_barrier | 0.73124654 |
78 | MP0005075_abnormal_melanosome_morpholog | 0.72801436 |
79 | MP0003690_abnormal_glial_cell | 0.72437836 |
80 | MP0005451_abnormal_body_composition | 0.72274228 |
81 | MP0009765_abnormal_xenobiotic_induced | 0.72254730 |
82 | MP0004381_abnormal_hair_follicle | 0.71834803 |
83 | MP0003045_fibrosis | 0.68616316 |
84 | MP0001542_abnormal_bone_strength | 0.68147634 |
85 | MP0003795_abnormal_bone_structure | 0.64628005 |
86 | MP0000490_abnormal_crypts_of | 0.62015154 |
87 | MP0000920_abnormal_myelination | 0.61964506 |
88 | MP0005165_increased_susceptibility_to | 0.59826058 |
89 | MP0008874_decreased_physiological_sensi | 0.59179623 |
90 | MP0002139_abnormal_hepatobiliary_system | 0.57960311 |
91 | MP0005381_digestive/alimentary_phenotyp | 0.57779020 |
92 | MP0002332_abnormal_exercise_endurance | 0.55799107 |
93 | MP0005319_abnormal_enzyme/_coenzyme | 0.54523087 |
94 | MP0002136_abnormal_kidney_physiology | 0.53312054 |
95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52905006 |
96 | MP0002693_abnormal_pancreas_physiology | 0.52779605 |
97 | MP0000015_abnormal_ear_pigmentation | 0.51209727 |
98 | MP0000569_abnormal_digit_pigmentation | 0.51035653 |
99 | MP0002019_abnormal_tumor_incidence | 0.49103931 |
100 | MP0005535_abnormal_body_temperature | 0.48659829 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 5.24396632 |
2 | Recurrent abscess formation (HP:0002722) | 5.08888497 |
3 | Abnormality of macrophages (HP:0004311) | 5.01661989 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92412487 |
5 | Myositis (HP:0100614) | 4.79033192 |
6 | Eczematoid dermatitis (HP:0000976) | 4.70021760 |
7 | Stomatitis (HP:0010280) | 4.67142939 |
8 | Optic neuritis (HP:0100653) | 4.34440653 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.34440653 |
10 | Orchitis (HP:0100796) | 4.30638147 |
11 | Obstructive lung disease (HP:0006536) | 3.93129175 |
12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.93129175 |
13 | T lymphocytopenia (HP:0005403) | 3.93101593 |
14 | Abnormality of T cell number (HP:0011839) | 3.92439042 |
15 | Increased IgM level (HP:0003496) | 3.70348399 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 3.66932861 |
17 | Meningitis (HP:0001287) | 3.63101381 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59344185 |
19 | Recurrent fungal infections (HP:0002841) | 3.55383343 |
20 | Recurrent skin infections (HP:0001581) | 3.50643491 |
21 | Vasculitis (HP:0002633) | 3.49415652 |
22 | Pulmonary infiltrates (HP:0002113) | 3.40160443 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.39173432 |
24 | Encephalitis (HP:0002383) | 3.37417768 |
25 | Petechiae (HP:0000967) | 3.35062879 |
26 | Chronic otitis media (HP:0000389) | 3.31549878 |
27 | Autoimmune hemolytic anemia (HP:0001890) | 3.31325886 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28069785 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28069785 |
30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28069785 |
31 | Autoimmune thrombocytopenia (HP:0001973) | 3.27123371 |
32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25294566 |
33 | Hemoptysis (HP:0002105) | 3.17619132 |
34 | Keratoconjunctivitis sicca (HP:0001097) | 3.13937196 |
35 | Purpura (HP:0000979) | 3.12772751 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10919849 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10919849 |
38 | Prolonged bleeding time (HP:0003010) | 3.08974108 |
39 | Recurrent bronchitis (HP:0002837) | 3.02392859 |
40 | Epistaxis (HP:0000421) | 3.02192427 |
41 | Spontaneous hematomas (HP:0007420) | 3.01327922 |
42 | Abnormality of T cells (HP:0002843) | 2.97803174 |
43 | Gangrene (HP:0100758) | 2.94611532 |
44 | Systemic lupus erythematosus (HP:0002725) | 2.91553547 |
45 | Keratoconjunctivitis (HP:0001096) | 2.91193541 |
46 | Leukocytosis (HP:0001974) | 2.89839920 |
47 | Urticaria (HP:0001025) | 2.88577679 |
48 | Chest pain (HP:0100749) | 2.87284199 |
49 | Gingival bleeding (HP:0000225) | 2.82211622 |
50 | Pustule (HP:0200039) | 2.80070301 |
51 | IgG deficiency (HP:0004315) | 2.79013558 |
52 | Recurrent viral infections (HP:0004429) | 2.78028046 |
53 | Increased cerebral lipofuscin (HP:0011813) | 2.77405373 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.66745454 |
55 | Arterial thrombosis (HP:0004420) | 2.64515789 |
56 | Eosinophilia (HP:0001880) | 2.61121743 |
57 | Gingivitis (HP:0000230) | 2.60666586 |
58 | Nasal polyposis (HP:0100582) | 2.58134601 |
59 | Pulmonary embolism (HP:0002204) | 2.58002888 |
60 | Abnormality of the prostate (HP:0008775) | 2.57581663 |
61 | Joint swelling (HP:0001386) | 2.56014071 |
62 | Granulocytopenia (HP:0001913) | 2.52137681 |
63 | Abnormality of the nasal mucosa (HP:0000433) | 2.51270376 |
64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50477681 |
65 | Amyloidosis (HP:0011034) | 2.49981725 |
66 | Anorexia (HP:0002039) | 2.48910245 |
67 | Chronic diarrhea (HP:0002028) | 2.44841295 |
68 | Abnormality of B cell number (HP:0010975) | 2.43776418 |
69 | Abnormality of the pleura (HP:0002103) | 2.43036210 |
70 | Agammaglobulinemia (HP:0004432) | 2.41747634 |
71 | Increased serum ferritin (HP:0003281) | 2.40454770 |
72 | Increased IgE level (HP:0003212) | 2.39440063 |
73 | Abnormality of eosinophils (HP:0001879) | 2.38375289 |
74 | Vacuolated lymphocytes (HP:0001922) | 2.38025515 |
75 | Polyneuropathy (HP:0001271) | 2.34861367 |
76 | Chronic sinusitis (HP:0011109) | 2.28598384 |
77 | Dysostosis multiplex (HP:0000943) | 2.23959322 |
78 | Glomerulopathy (HP:0100820) | 2.20890993 |
79 | Abnormality of T cell physiology (HP:0011840) | 2.17825029 |
80 | Abnormality of iron homeostasis (HP:0011031) | 2.17659223 |
81 | Panhypogammaglobulinemia (HP:0003139) | 2.16895248 |
82 | Loss of speech (HP:0002371) | 2.16612010 |
83 | Inflammation of the large intestine (HP:0002037) | 2.15812945 |
84 | Vertigo (HP:0002321) | 2.13157086 |
85 | Episodic fever (HP:0001954) | 2.12734197 |
86 | Basal ganglia calcification (HP:0002135) | 2.11948121 |
87 | Severe combined immunodeficiency (HP:0004430) | 2.07193660 |
88 | Skin rash (HP:0000988) | 2.07089966 |
89 | Hypoproteinemia (HP:0003075) | 2.06970021 |
90 | Lymphopenia (HP:0001888) | 2.05356121 |
91 | B lymphocytopenia (HP:0010976) | 2.03702048 |
92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03302095 |
93 | Disinhibition (HP:0000734) | 2.00793707 |
94 | Hepatosplenomegaly (HP:0001433) | 2.00676596 |
95 | Arthralgia (HP:0002829) | 2.00354870 |
96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98285254 |
97 | Alveolar cell carcinoma (HP:0006519) | 1.96717298 |
98 | Gastrointestinal inflammation (HP:0004386) | 1.96633409 |
99 | Premature loss of primary teeth (HP:0006323) | 1.95656605 |
100 | IgM deficiency (HP:0002850) | 1.94679845 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.20585321 |
2 | RIPK4 | 4.06820127 |
3 | MAP4K1 | 3.56594659 |
4 | BMPR2 | 3.19410890 |
5 | TAOK3 | 2.97689336 |
6 | BLK | 2.96143337 |
7 | MAP3K13 | 2.52620215 |
8 | MAP3K14 | 2.37639588 |
9 | TYK2 | 2.34198678 |
10 | CSK | 2.32817321 |
11 | FES | 2.26725137 |
12 | ZAP70 | 2.17971407 |
13 | BTK | 2.11131956 |
14 | IRAK4 | 2.08649027 |
15 | SYK | 2.07926887 |
16 | JAK3 | 2.02367569 |
17 | TBK1 | 1.93797932 |
18 | IKBKE | 1.92291930 |
19 | GRK6 | 1.90256691 |
20 | IKBKB | 1.87580586 |
21 | TESK2 | 1.84331690 |
22 | CSF1R | 1.81823894 |
23 | GRK7 | 1.77459359 |
24 | TLK1 | 1.76275957 |
25 | LYN | 1.74818402 |
26 | KDR | 1.74476167 |
27 | MAP3K12 | 1.67628624 |
28 | MAP2K3 | 1.65013697 |
29 | KIT | 1.61262539 |
30 | TNK2 | 1.57103655 |
31 | TEC | 1.55669372 |
32 | ITK | 1.53324439 |
33 | FGR | 1.50507532 |
34 | HCK | 1.47960476 |
35 | MAP3K11 | 1.46647203 |
36 | LCK | 1.41110460 |
37 | MATK | 1.39660043 |
38 | JAK1 | 1.35432332 |
39 | PIK3CG | 1.25221864 |
40 | IRAK3 | 1.18986864 |
41 | MAP3K3 | 1.18807793 |
42 | TAOK2 | 1.18675006 |
43 | ERN1 | 1.11279358 |
44 | JAK2 | 1.11073830 |
45 | TGFBR2 | 1.03655918 |
46 | ADRBK2 | 1.01003087 |
47 | MYLK | 0.98697970 |
48 | MARK3 | 0.84652853 |
49 | MOS | 0.82493608 |
50 | TAOK1 | 0.82318072 |
51 | MAP3K1 | 0.81110340 |
52 | CDK19 | 0.71832432 |
53 | SIK3 | 0.70947860 |
54 | TESK1 | 0.69776994 |
55 | PRPF4B | 0.67284669 |
56 | PIM1 | 0.67250293 |
57 | IRAK1 | 0.66882661 |
58 | MST4 | 0.65869158 |
59 | ARAF | 0.65757185 |
60 | MAP3K5 | 0.64846532 |
61 | ACVR1B | 0.63596878 |
62 | PRKCQ | 0.63024092 |
63 | FYN | 0.62529458 |
64 | ILK | 0.58497542 |
65 | PDK1 | 0.57585571 |
66 | CHUK | 0.54107826 |
67 | MAP2K6 | 0.52472105 |
68 | NME2 | 0.52258535 |
69 | CAMKK2 | 0.47469278 |
70 | GRK5 | 0.45994077 |
71 | STK10 | 0.45096305 |
72 | PIM2 | 0.44940256 |
73 | BCKDK | 0.44150646 |
74 | ABL1 | 0.42483652 |
75 | IGF1R | 0.40311384 |
76 | DAPK3 | 0.39344143 |
77 | IRAK2 | 0.36124231 |
78 | PRKCD | 0.36094839 |
79 | DAPK1 | 0.33910900 |
80 | PDPK1 | 0.33865150 |
81 | PTK2B | 0.33501111 |
82 | EPHB1 | 0.33458697 |
83 | EGFR | 0.31959887 |
84 | MAPK7 | 0.30646598 |
85 | DAPK2 | 0.29592963 |
86 | ABL2 | 0.29543731 |
87 | MAPKAPK2 | 0.28679707 |
88 | CDC42BPA | 0.28613474 |
89 | BMX | 0.28602272 |
90 | TRPM7 | 0.27804019 |
91 | PAK1 | 0.27154755 |
92 | LRRK2 | 0.25584352 |
93 | CLK1 | 0.20722070 |
94 | MAPK12 | 0.20651495 |
95 | ADRBK1 | 0.20064560 |
96 | SCYL2 | 0.19779066 |
97 | INSR | 0.19773537 |
98 | DYRK1B | 0.18712347 |
99 | MAP4K2 | 0.17810365 |
100 | HIPK2 | 0.17393176 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.90154516 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.89795183 |
3 | Asthma_Homo sapiens_hsa05310 | 3.70142467 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.64151510 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17714883 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.96472145 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.96303779 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92123334 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.78419492 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.67073917 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.61028718 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.34869140 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25580087 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14186239 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08586615 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07568742 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 2.07188244 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.01511015 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.91962557 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.89557060 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86939034 |
22 | Malaria_Homo sapiens_hsa05144 | 1.75523333 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.60746097 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48896947 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.47522871 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45796871 |
27 | Measles_Homo sapiens_hsa05162 | 1.44239978 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42814271 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.42424313 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38529534 |
31 | Phagosome_Homo sapiens_hsa04145 | 1.31209262 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.29693967 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29033273 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25475152 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24480208 |
36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22115197 |
37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21509237 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20618863 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.09471958 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09456474 |
41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09059466 |
42 | Shigellosis_Homo sapiens_hsa05131 | 1.04588743 |
43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97832387 |
44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96913575 |
45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96114548 |
46 | Platelet activation_Homo sapiens_hsa04611 | 0.94404576 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91629488 |
48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81059645 |
49 | Apoptosis_Homo sapiens_hsa04210 | 0.72807574 |
50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68238636 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64826697 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64079636 |
53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61024765 |
54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60153311 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59965369 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 0.57978047 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 0.57724043 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53470812 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52867562 |
60 | Proteasome_Homo sapiens_hsa03050 | 0.52659494 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50865958 |
62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49826429 |
63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49067757 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48348857 |
65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44406227 |
66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40899514 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39714700 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38550134 |
69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34388337 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34150133 |
71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32845140 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.32176510 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.31649831 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31318604 |
75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30088198 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29406184 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26302714 |
78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21165397 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18993957 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17309466 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.17048842 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16927008 |
83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16396879 |
84 | Bladder cancer_Homo sapiens_hsa05219 | 0.15776226 |
85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13860236 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13504746 |
87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13202990 |
88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12503350 |
89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10761289 |
90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.10528898 |
91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10099056 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.09911215 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.09768503 |
94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.08038945 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07397914 |
96 | Mineral absorption_Homo sapiens_hsa04978 | 0.07196370 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.06753970 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04384766 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04106892 |
100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03375474 |